Muna Adam/LinkedIn
Jul 24, 2026, 08:57
Muna Adam: Plasma-Derived Factor X Concentrate Used in First UAE Roma Variant Cases
Muna Adam, Clinical Hematologist at Sheikh Shakhbout Medical City, shared a post on LinkedIn:
“Proud to have presented my Poster at ISTH 2026 in Paris.
‘Type II Factor X Deficiency Due to the Roma Variant (p.Thr358Met): First Reported Cases from the United Arab Emirates Treated with Plasma-Derived Factor X Concentrate.’
Grateful for the opportunity to contribute to the global rare bleeding disorders community.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?